Rahman, M.M.; Behl, T.; Islam, M.R.; Alam, M.N.; Islam, M.M.; Albarrati, A.; Albratty, M.; Meraya, A.M.; Bungau, S.G.
Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer. Molecules 2022, 27, 3798.
https://doi.org/10.3390/molecules27123798
AMA Style
Rahman MM, Behl T, Islam MR, Alam MN, Islam MM, Albarrati A, Albratty M, Meraya AM, Bungau SG.
Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer. Molecules. 2022; 27(12):3798.
https://doi.org/10.3390/molecules27123798
Chicago/Turabian Style
Rahman, Md. Mominur, Tapan Behl, Md. Rezaul Islam, Md. Noor Alam, Md. Mohaimenul Islam, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, and Simona Gabriela Bungau.
2022. "Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer" Molecules 27, no. 12: 3798.
https://doi.org/10.3390/molecules27123798
APA Style
Rahman, M. M., Behl, T., Islam, M. R., Alam, M. N., Islam, M. M., Albarrati, A., Albratty, M., Meraya, A. M., & Bungau, S. G.
(2022). Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer. Molecules, 27(12), 3798.
https://doi.org/10.3390/molecules27123798